BioMap BioMap

BioMap is an AI-driven research and development company focusing on precision medicine. The company is committed to bringing first-in-class medicine to unmet medical needs for patients by applying modern A.I./Data science to the entire life cycle of drug discovery, with a long-term vision and strong funding. To design advanced, complex, and next-generation antibodies, BioMap's AI antibody design platform combines high throughput biological technologies with machine learning processes. Unsupervised learning is used to train a deep sequence representation model on hundreds of millions of protein sequences from various evolutionary models. This is applied to downstream tasks such as antibody structure prediction and biological activity prediction.